1. Discovery of a functionally selective ghrelin receptor (GHSR 1a ) ligand for modulating brain dopamine.
- Author
-
Gross JD, Kim DW, Zhou Y, Jansen D, Slosky LM, Clark NB, Ray CR, Hu X, Southall N, Wang A, Xu X, Barnaeva E, Wetsel WC, Ferrer M, Marugan JJ, Caron MG, Barak LS, and Toth K
- Subjects
- Animals, Dopamine genetics, GTP-Binding Protein alpha Subunits, Gq-G11 genetics, Male, Mice, Mice, Knockout, Receptors, Ghrelin genetics, Brain metabolism, Dopamine metabolism, GTP-Binding Protein alpha Subunits, Gq-G11 metabolism, Receptors, Ghrelin metabolism
- Abstract
SignificanceThe modulation of growth hormone secretagogue receptor-1a (GHSR
1a ) signaling is a promising strategy for treating brain conditions of metabolism, aging, and addiction. GHSR1a activation results in pleiotropic physiological outcomes through distinct and pharmacologically separable G protein- and β-arrestin (βarr)-dependent signaling pathways. Thus, pathway-selective modulation can enable improved pharmacotherapeutics that can promote therapeutic efficacy while mitigating side effects. Here, we describe the discovery of a brain-penetrant small molecule, N8279 (NCATS-SM8864), that biases GHSR1a conformations toward Gαq activation and reduces aberrant dopaminergic behavior in mice. N8279 represents a promising chemical scaffold to advance the development of better treatments for GHSR1a -related brain disorders involving the pathological dysregulation of dopamine.- Published
- 2022
- Full Text
- View/download PDF